Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CTR20262689 PTT-621 Colitis, Ulcerative Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262689 clinical trial report covering PTT-621, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262866 Qilong dingchuan Tablets Pulmonary Disease, Chronic Obstructive Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262866 clinical trial report covering Qilong dingchuan Tablets, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262790 VB19055 Resistant hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262790 clinical trial report covering VB19055, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262743 SV-003 Hemophilia A Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262743 clinical trial report covering SV-003, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600129027 Granisetron Hydrochloride Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
ChiCTR2600129027 clinical trial report covering Granisetron Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white spa
Latest Hotspot
8 min read
NCT07548632 Licaminlimab Dry Eye Syndromes Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07548632 clinical trial report covering Licaminlimab, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07548996 Dimethyl fumarate Diabetes Mellitus, Type 1 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07548996 clinical trial report covering Dimethyl fumarate, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07554456 Tislelizumab Metastatic Esophageal Squamous Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07554456 clinical trial report covering Tislelizumab, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07555392 CHIKUNGUNYA Vaccine(Bharat Biotech International Limited) Chikungunya Fever Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07555392 clinical trial report covering CHIKUNGUNYA Vaccine(Bharat Biotech International Limited), Phase 2/3, endpoints, sponsor, geography, readout tim
Latest Hotspot
8 min read
NCT07556991 Amoxicillin/Clavulanate Potassium Hematoma, Subdural, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07556991 clinical trial report covering Amoxicillin/Clavulanate Potassium, Phase 2/3, endpoints, sponsor, geography, readout timing and development whit
Latest Hotspot
8 min read
NCT07570173 Tocilizumab-anoh CD19-positive B-cell acute lymphoblastic leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07570173 clinical trial report covering Tocilizumab-anoh, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07571681 Colchicine Hashimoto Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07571681 clinical trial report covering Colchicine, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.